The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | G | Genito urinary system and sex hormones | |
2 | G03 | Sex hormones and modulators of the genital system | |
3 | G03A | Hormonal contraceptives for systemic use | |
4 | G03AD | Emergency contraceptives |
Code | Title | |
---|---|---|
G03AD01 | Levonorgestrel | |
G03AD02 | Ulipristal |
Active Ingredient | Description | |
---|---|---|
Levonorgestrel |
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
|
Ulipristal |
Ulipristal is an orally-active synthetic selective progesterone receptor modulator which acts via high-affinity binding to the human progesterone receptor. When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge. Pharmacodynamic data show that even when taken immediately before ovulation is scheduled to occur (when LH has already started to rise), ulipristal acetate is able to postpone follicular rupture for at least 5 days. |
Title | Information Source | Document Type | |
---|---|---|---|
ELLA Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ELLAONE Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
EMERRES Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ESCAPELLE Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
EZINELLE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
LEVONELLE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NORLEVO Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |